The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Small intestinal bacterial overgrowth in Parkinson's disease
Abstract
Background Recent studies reported a high prevalence of small intestinal bacterial overgrowth (SIBO) in Parkinson's disease (PD), and a possible association with gastrointestinal symptoms and worse motor function. We aimed to study the prevalence and the potential impact of SIBO on gastrointestinal symptoms, motor function, and quality of life in a large cohort of PD patients.Methods 103 Consecutive PD patients were assessed using the lactulose-hydrogen breath test; questionnaires of gastrointestinal symptoms and quality of life (PDQ-39); the Unified PD Rating Scale (UPDRS) including "on"-medication Part III (motor severity) score; and objective and quantitative measures of bradykinesia (Purdue Pegboard and timed test of gait). Patients and evaluating investigators were blind to SIBO status.Results 25.3% of PD patients were SIBO-positive. SIBO-positive patients had a shorter mean duration of PD (5.2 ± 4.1 vs. 8.1 ± 5.5 years, P = 0.007). After adjusting for disease duration, SIBO was significantly associated with lower constipation and tenesmus severity scores, but worse scores across a range of "on"-medication motor assessments (accounting for 4.2-9.0% of the variance in motor scores). There was no association between SIBO and motor fluctuations or PDQ-39 Summary Index scores.Conclusions This is the largest study to date on SIBO in PD. SIBO was detected in one quarter of patients, including patients recently diagnosed with the disease. SIBO was not associated with worse gastrointestinal symptoms, but independently predicted worse motor function. Properly designed treatment trials are needed to confirm a causal link between SIBO and worse motor function in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PD patients suffering from SIBO were not reported to develop worse GI dysfunction.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“However, they were independently predisposed to worse motor-dysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
Citations
Cites
Gastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428
Nutl, J. G., & Fellman, J. H. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198403000-00002 · Cited by 357
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lombardo, L., Foti, M., Ruggia, O., & Chiecchio, A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.12.022 · Cited by 350
The role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344
Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Quigley, E. M. M., & Quera, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.046 · Cited by 330
A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth
Khoshini, R., Dai, S.-C., Lezcano, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0065-1 · Cited by 323
Small intestinal bacterial overgrowth: a comprehensive review.
(2007) · PubMed Central · Cited by 321
Cited by
Sorted by citations
Items 201–274 of 274
Kim, Y.-J., Lee, C., Kim, S., Jang, J., Lee, S., & Lee, S.-H. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09617-1 · Cited by 5
Szablewski, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00065-6 · Cited by 5
Consequences of Gut Dysbiosis on the Human Brain
Hickman, R. A., Hussein, M. A., & Pei, Z. (2016) · InTech eBooks · doi:10.5772/64690 · Cited by 5
Ambrosini, Y. M., Borcherding, D. C., Kanthasamy, A. G., Kim, H. J., Jergens, A. E., Allenspach, K., & Mochel, J. P. (2019) · Preprints.org · doi:10.20944/preprints201901.0275.v1 · Cited by 4
Lactobacillaceae and Parkinson's disease: An apparent paradox
van der Maden, M. M., Verbeek, M. M., & Beckers, M. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241312401 · Cited by 5
Seneff, S., Nigh, G., & Kyriakopoulos, A. M. (2025) · Biocell · doi:10.32604/biocell.2025.066687 · Cited by 4
Abdelaziz, A. I., Gad, A. M., & Azab, S. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823304-7.00012-x · Cited by 4
Gut Microbes in Parkinson's Disease
Markidi, A., Elford, J. D., Berkers, C. R., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00002-3 · Cited by 4
STW5 (Iberogast®) for constipation in Parkinson's disease
Roy, M., Péré, M., Damier, P., Varannes, S. B. D., Derkinderen, P., & Rouaud, T. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.06.005 · Cited by 4
Spotlight on non-motor symptoms and Covid-19
Rota, S., Boura, I., Wan, Y.-M., Lazcano‐Ocampo, C., Rodríguez‐Violante, M., Antonini, A., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.001 · Cited by 4
Zhou, Q., Yang, B., Zhu, Y., Wang, F., Tai, Y., Liu, Z., Chen, J., Liang, C., Yang, H., Pang, A., et al. (2024) · Brain Imaging and Behavior · doi:10.1007/s11682-024-00948-w · Cited by 4
Management of Gastrointestinal Symptoms in Parkinson’s Disease
Chiang, H., & Lin, C. (2025) · Journal of Central Nervous System Disease · doi:10.1177/11795735251370014 · Cited by 3
Fecal Microbiota Transplants as a Treatment Option for Parkinson’s Disease
Flameling, I. A., & Rijkers, G. T. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78666 · Cited by 3
Microbiota-Gut-Brain Axis in Neurological Disorders
Sundaram, S., Ponnambath, D. K., & Nair, S. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-7672-7_7 · Cited by 4
The gut microbiome as a factor in the development of Parkinson's disease
Арамайисовна, Б. Л., Poluektova, E. A., & Poluektov, M. G. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-1-90-96 · Cited by 3
Reconsidering molecular hydrogen deficits: A potential target for intervention?
Todorović, N., & Ostojić, S. M. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111116 · Cited by 3
Chaudhuri, К. R., & Batzu, L. (2023) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13915 · Cited by 3
Bhardwaj, K., Singh, A. A., & Kumar, H. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00293 · Cited by 4
Nutrition in Parkinson’s disease
Gorzkowska, A. (2017) · Aktualności Neurologiczne · doi:10.15557/an.2017.0022 · Cited by 3
Goh, X. Y., Shambetova, C., Toh, T. S., Zhunusova, E., Tay, Y. W., Chua, J. P., Han, W. H., Lim, J. Y. L., Tan, A. H., & Lim, S. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261479268 · Cited by 2
Effects of indoxyl sulfate on dopaminergic neurons and motor functions
Oh, M., Choi, J., Ju, I. G., Huh, E., Noh, D., & Gu, P. S. (2020) · Journal of Pharmaceutical Negative Results · doi:10.4103/jpnr.jpnr_23_19 · Cited by 2
Sex Differences and Gut Microbiota Changes in Parkinson’s Disease
Lee, J., & Shin, C. M. (2022) · Springer eBooks · doi:10.1007/978-981-19-0120-1_24 · Cited by 2
Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
Ali, A., Yin, N. B., Rehman, A., & Justilien, V. (2016) · Medical Sciences · doi:10.3390/medsci4010001 · Cited by 2
Вячеславович, К. И., Litvinenko, I., Родионов, Г. Г., Игнатьевич, Ш. И., & Светкина, Е. В. (2019) · Human Physiology · doi:10.1134/s036211971908005x · Cited by 2
Alonso-García, P., Martín, R., & Martínez‐Pinilla, E. (2021) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2021.00005 · Cited by 2
Ткач, С. М., Dorofeyev, A., Kuzenko, I., Boyko, N., Falalyeyeva, T. M., & Kobyliak, N. M. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_10 · Cited by 2
Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies
Trubitsina, N. P., Matiiv, A. B., Rogoza, T. M., Zudilova, A. A., Bezgina, M. D., Zhouravleva, G. A., & Bondarev, S. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924030118 · Cited by 2
Gastrointestinal Disturbances in Parkinson’s Disease Including the Management of Sialorrhea
Jost, W. H., & Klingelhoefer, L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009039291.014 · Cited by 1
Gastrointestinal Surgery and Risk of Parkinson Disease: A Meta-Analysis
Wang, P., Zheng, M., Wang, Y., Jia, Z., Zhou, T., & Zu, G. (2024) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2024.01.86 · Cited by 1
Movement disorders associated with diarrhoea
Lazcano‐Ocampo, C., Warnecke, T., Boura, I., Urso, D., Leta, V., Popławska-Domaszewicz, K., Batzu, L., Bayram, E., Raeder, V., Lin, C., et al. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02924-0 · Cited by 1
Therapeutic potential of phytochemicals and role of gut microbiota in neurodegenerative diseases
Gupta, S. K., & Sharma, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36372-6.00014-8 · Cited by 1
Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson’s Disease
Feix, J. B., Cheng, G., Hardy, M., & Kalyanaraman, B. (2026) · Antioxidants · doi:10.3390/antiox15010120 · Cited by 2
Johnson, M., & Johnson, J. L. (2016) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Clinical and Pre-Clinical Evidence for Enteric α-Synuclein Involvement in Parkinson's Disease
Kochman, E. M., Akhtar, K., Ali, A., & Shin Damian, S. (2021) · International Journal of Neurodegenerative Disorders · doi:10.23937/2643-4539/1710019 · Cited by 2
Microbiota and Neurodegenerative Diseases
Khan, M. F., & Banerjee, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00098-x · Cited by 1
The role of the gut microbiota in Parkinson’s disease
Verugina, N. I., Levin, O. S., & Lyashenko, E. A. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112110286 · Cited by 1
Gut Microbiota Changes and Parkinson’s Disease: What Do We Know, Which Avenues Ahead
Hirayama, M., & Ohno, K. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_13 · Cited by 1
Neurology and the gut: Autonomic neuropathy and dysautonomia
Ghafoor, A., Sundar, S., Karunaratne, T. B., Rao, S. S. C., & Sharma, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13911-6.00028-1 · Cited by 1
Parkinson's Disease, Diet and Gut Microbiota Alterations
Guach-Hevia, D. A. (2023) · Journal of Neurodegenerative Disorders · doi:10.36959/459/610 · Cited by 1
Rajeev, A., & Chattopadhyay, I. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_13 · Cited by 1
Interplay Between Gut-microbiota and Neurodegeneration
Ashique, S., Pal, R., Kumar, S., Verma, B., Kumar, N., Kahwa, I., Farid, A., Mishra, N., Kumar, P., & Taghizadeh‐Hesary, F. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010009 · Cited by 1
Microbiome and Neurological Disorders
Ijaz, M. U., Akbar, A., Ashraf, A., Yeni, D. K., Naz, H. U., & Shahid, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_9 · Cited by 1
The fixel GI Parkinson's research and integrated support model (PRISM)
Hey, G. E., Amaris, M. A., Beke, M., Walker-Pizarro, N., Rogers, C., Vedam‐Mai, V., Dorsey, R., Herndon, N. E., Okun, M. S., & Ramirez‐Zamora, A. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251335047 · Cited by 1
Ovallath, S., & Sulthana, B. (2018) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_4_18 · Cited by 1
Nutrition Therapy for Intestinal Disorders
Haller, E., Issokson, K., Lebovits, J., & Scarlata, K. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_29-1 · Cited by 1
The role of the gastrointestinal system and gut microbiota in Parkinson's disease
Kenna, J. E., & Anderton, R. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00036-9 · Cited by 1
Interlinking dementia in Parkinson's disease: nutritional correlates of body composition
Schelp, A. O., Komuro, J. E., Corrente, J. E., & Papini, S. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00035-7 · Cited by 1
Nutrition Therapy for Intestinal Disorders
Haller, E., Issokson, K., Lebovits, J., & Scarlata, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_29 · Cited by 1
Micronutrients and Parkinson’s Disease
Azmin, S., Rani, R. M., & Ibrahim, N. M. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_9 · Cited by 1
A New Perspective on Parkinson’s Disease: Pathology Begins in the Gastrointestinal Tract
Mau, K. J., & Jadavji, N. M. (2017) · doi:10.22186/jyi.33.4.63-70 · Cited by 1
Mashaly, M. E.-S., Saudy, N., Belal, T., & Motawei, S. M. (2017) · Comparative Clinical Pathology · doi:10.1007/s00580-017-2460-0
Modulation of Parkinson's disease by the gut microbiota
Eshaghpour, A., Hassan, M. I., Sager, M., Ad-Dab’bagh, Y., & Akhtar, M. (2018) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/ijmbs.ijmbs_68_18
Human Gut Microbiota: Friend or Foe?
Pliszka, M., & Szablewski, L. (2020) · OBM Hepatology and Gastroenterology · doi:10.21926/obm.hg.2003050
Interrelationship between Gut microbiota and Parkinson’s disease
Shivananjappa, M. M., Manasa, R., Prakruthi, M., & Shekhara Naik, R. (2020) · IP Journal of Nutrition Metabolism and Health Science · doi:10.18231/j.ijnmhs.2020.015
Probiotics: Not just good for the gut but for the brain too
Mahadeva, S. (2021) · JGH Open · doi:10.1002/jgh3.12505
Interplay between gut bacteria and Parkinson’s disease medication
van Kessel, S. P. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.182831964
Miller, G. W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734885415.793558390
Fung, V. S. C., & Morales‐Briceño, H. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734885415.793558045
Non-Oral Drug Delivery Strategies: From Early Diagnosis to Advanced Treatments
Wolstencroft, K. (2015) · EMJ Neurology · doi:10.33590/emjneurol/10314470
Effects of Metabolic Syndrome on Parkinson’s Disease and Nutraceutical Intervention Strategies
Komuro, J. E., dos Santos, D. F. B., Schelp, A. B., Papini, S. J., & Schelp, A. O. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108956
Guo, C., Ma, D., Zhang, C., Wang, Y., Ullah, F., Wang, X., Lee, Y., & Zhang, G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4822319
Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies (Review)
Trubitsina, N. P., Matiiv, A. B., Rogoza, T. M., Zudilova, A. A., Bezgina, M. D., Zhouravleva, G. A., & Bondarev, S. A. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524030089
Neurobehavioral characterization of PD models
Al-Hafiry, S. A., Albaba, F. Z., Yassin, N. W., Abbas, F. M., & Haboush, R. J. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00018-9
İlhan, S. (2024) · Journal of Immunology and Clinical Microbiology · doi:10.58854/jicm.1583436
Triadafilopoulos, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-77171-2_3
Role of microbiota gut–brain axis in Parkinson's disease
Mansuri, R., Dhanawat, M., Patel, S., Garima, G., & Diwan, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00003-1
Nápoles-Medina, A. Y., Aguilar-Uscanga, B. R., Nápoles-Medina, B. G., Brand-Rubalcava, P. A., Tejeda-Martínez, A. R., & Flores-Soto, M. E. (2025) · Neurology Perspectives · doi:10.1016/j.neurop.2025.100206
The ‘gut feeling’: Connecting neurodegenerative diseases and gut microbiota
Niyogi, S., & Basu, S. (2026) · The Microbe · doi:10.1016/j.microb.2026.100719
Madny, M. A., & Yadav, K. S. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115179
Metadata
- Authors
- Tan, A. H., Mahadeva, S., Thalha, A. M., Gibson, P. R., Kiew, C. K., Yeat, C. M., Ng, S. W., Ang, S. P., Chow, S. K., Tan, C. T., Yong, H. S., Marras, C., Fox, S. H., & Lim, S.-Y.
- Affiliations
- University of Malaya (MY)
- The Alfred Hospital (AU)
- University of Toronto (CA)
- Corresponding author
- Lim, Shen-Yang
- ORCID
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 20
- Issue
- 5
- Pages
- 535-540
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W1983564695
- Cited by
- 274
- References
- 34
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 39 · 2020: 34 · 2019: 25 · 2018: 28 · 2017: 20 · 2016: 11 · 2015: 15 · 2014: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Malaysian Ministry of Higher Education
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- small intestinal bacterial overgrowth, Parkinson's disease
- MeSH terms
- Aged, Bacterial Infections, Female, Humans, Hydrogen, Intestinal Diseases, Lactulose, Male, Middle Aged, Parkinson Disease, Quality of Life, Surveys and Questionnaires, Regression Analysis, Severity of Illness Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review